fep blue glp 1 coverage 2026 📢 Two important dates for patients interested in GLP-1 medications: ✓ July 1, – Medicare GLP-1 Bridge Program begins for eligible Medicare Part D beneficiaries. ✓ October 1, 2026 – Zepbound Insurance coverage just changed for

Basal glucose can be controlled, but the prandial problem persists- its the next target Diabetes Care

If youre not seeing the expected appetite changes or have any concerns, its essential to discuss them with your healthcare provider, who can adjust your treatment plan accordingly

The goal was simple: to explore how these medications may be connected to changes in cycles, ovulation, hormones, and overall wellbeing

The updated warnings for Mounjaro and Trulicity come in the wake of new warnings for gastrointestinal issues being added to market-leading diabetes drug Ozempic earlier this year

GLP-1 therapies are integrated into a broader regimen, and discontinuation is typically considered within the context of overall disease management

Key facts: Medicaid launch : as early as May 2026 Participation : voluntary for states states must opt in Pricing : CMS negotiates directly with Eli Lilly (Zepbound/Mounjaro) and Novo Nordisk (Wegovy/Ozempic)